SpectraA Technology Solutions opened for subscription on 17 Sept and closes on 21 Sept 2026. GMP is ₹30 (about 25.4% over the cap price), and the issue is 5.66x subscribed so far.
SpectraA Technology Solutions IPO Subscription Status
| Category | Subscribed (times) | Bids received |
|---|---|---|
| QIB | 184.55x | ₹1262.30 cr |
| NII (HNI) | 441.66x | ₹2273.65 cr |
| Retail | 313.16x | ₹3750.41 cr |
| Total | 304.05x | ₹7286.36 cr |
Updated through the bidding window; final numbers settle after the issue closes.
SpectraA Technology Solutions IPO GMP (Grey Market Premium)
The latest grey market premium for SpectraA Technology Solutions is ₹67 (about 56.8% over the cap price). GMP is an unofficial, over-the-counter figure that can change through the day and is not endorsed by SEBI or the exchanges.
Should You Apply to SpectraA Technology Solutions IPO?
As things stand, the grey market premium points to a listing near ₹148 (about 25.4%), the issue is subscribed 5.66x overall so far, retail is at 3.27x. In the company's favour: In-house design, engineering, and manufacturing capabilities across process industries. The main risk to weigh: A significant portion of revenue relies on a limited number of customers. Judge the price against the company's earnings and your holding period, not the GMP alone.
How to Apply for SpectraA Technology Solutions IPO
- Log in to your broker's IPO section and select SpectraA Technology Solutions.
- Bid at the cut-off price for the best chance of allotment (retail).
- Enter the number of lots (minimum 1,200 shares) and submit your UPI ID.
- Approve the mandate request in your UPI app before the cut-off time to block the funds.
Quick facts: Price band ₹112 – ₹118 · Lot 1,200 shares (~₹2,83,200) · Bidding 17 Sept – 21 Sept · Listing 24 Sept on NSE SME
More on SpectraA Technology Solutions IPO
- SpectraA Technology Solutions IPO — live GMP, subscription & allotment status
- SpectraA Technology Solutions IPO listing gain calculator
- All SME IPOs
- Full IPO list with GMP
This article is for information only and is not investment advice. Read the RHP and consider your own risk profile before investing.
Loading comments...